ResMed Inc.
Rank #145HypergrowthRMD · NYSE · Healthcare
ResMed Inc. (RMD) — Rank #145 by gross profitability (GP/assets 0.38) · ROE 23.1% · Piotroski F-Score 7 / 9.
As-of 2026-09-15 · CIK 0000943819 · all metrics point-in-time as of the filing date.
About
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally.
Show moreShow less
It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc.
was founded in 1989 and is headquartered in San Diego, California.
- Industry
- Medical Instruments & Supplies
- Sector
- Healthcare
- State
- DE
- Filer Category
- Large accelerated filer
- Fiscal Year End
- June 30
- Website
- resmed.com
Financials
Stable
Direction over 5 fiscal years
- Free cash flowimproving
- Gross marginstable
- Gross profitabilitystable
- Net cashdeteriorating
- Operating marginimproving
- Return on equityimproving
- Share count (dilution)deteriorating
Monitoring diagnostic of business direction — not a prediction of returns.
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2020-06-30filed 2020-08-13 | 2019-06-30filed 2019-08-08 | 2018-06-30filed 2018-08-17 | 2017-06-30filed 2017-08-04 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 2,957.0 | 2,606.6 | 2,340.2 | 2,066.7 |
| Revenue growth (YoY) | 13.4% | 11.4% | 13.2% | 12.4% |
| Gross profit | 1,717.8 | 1,536.6 | 1,362.2 | 1,201.7 |
| Gross margin | 58.1% | 59.0% | 58.2% | 58.1% |
| Net income | 621.7 | 404.6 | 315.6 | 342.3 |
| Net margin | 21.0% | 15.5% | 13.5% | 16.6% |
| EPS (diluted) | $4.27 | $2.80 | $2.19 | $2.40 |
| EPS growth (YoY) | 52.5% | 27.9% | -8.8% | — |
| Cash flow | ||||
| Operating cash flow | 802.3 | 459.1 | 505.0 | 414.1 |
| Capital expenditures | 95.3 | 68.7 | 62.6 | 62.2 |
| Free cash flow | 706.9 | 390.3 | 442.4 | 351.8 |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?